Targeting Fyn Kinase in Alzheimer's Disease. - Wikidata - awgldk - TriplyDB

Targeting Fyn Kinase in Alzheimer's Disease.

Targeting Fyn Kinase in Alzheimer's Disease.

http://www.wikidata.org/entity/Q38678555

about

Emerging Mechanisms in Alzheimer's Disease and Their Therapeutic Implications.The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.

P2860

Q50056287-9C58EF26-74C0-43EB-AEA5-1F38F4CDAA1F Q54977832-BEF46807-5082-47CA-B6B8-E51F2AEB9D27

P2860

Targeting Fyn Kinase in Alzheimer's Disease.

http://www.wikidata.org/entity/Q38678555

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Targeting Fyn Kinase in Alzheimer's Disease.

@en

type

label

Targeting Fyn Kinase in Alzheimer's Disease.

@en

prefLabel

Targeting Fyn Kinase in Alzheimer's Disease.

@en

P1433

Q38678555-DE53D855-1A34-40B5-925E-C45915882495

P1476

Q38678555-6C57C2A6-F522-49B9-969D-804EF97BD5B6

P2093

Q38678555-F6990592-4E6B-4EFD-B43F-E0772DB94DF3

P2860

Q38678555-0271AB2B-0073-47DB-A601-3DBE4131FC11

Q38678555-07AEA7E6-C7A1-4A41-8E0E-FC5772D7DCE3

Q38678555-095BC6A2-6150-4998-9E53-62EA9C8883FB

Q38678555-0A8739CE-DA7C-461A-842E-790FEB4039F3

Q38678555-0E1F2065-8A3F-4EAD-A25B-CF0494BAA6ED

Q38678555-0E99EE9B-C4A3-4B1C-9479-8619C55F395B

Q38678555-0E9DA22B-9F17-4A27-A35C-0DF98FD3178C

Q38678555-133A3F99-8A83-49F8-A9B1-94A625288B8A

Q38678555-13679CC4-1D65-4566-9BCD-63C92BBAA2F9

Q38678555-165917FE-221C-4625-8F5F-6DFF3B0AEC6D

P31

Q38678555-F8B63590-D780-477F-BC06-D747FE11BE92

P356

Q38678555-DEE8580B-A348-4028-B7D8-BF6607A0FE0F

P407

Q38678555-C9A81254-6670-4F9C-A92D-2A7A46968F67

P577

Q38678555-42E96319-90FB-4C04-98D0-AE5B15E9292B

P698

Q38678555-C3E719A1-FF23-4870-ABF9-362EE628CAAC

P921

Q38678555-2F2BD39B-629F-42C9-9072-F4979236CD0F

P932

Q38678555-198C712F-1969-4DE3-9D44-07C55DC963FB

P356

J.BIOPSYCH.2017.06.004

P1433

Biological Psychiatry

P1476

Targeting Fyn Kinase in Alzheimer's Disease.

@en

P2093

Haakon B Nygaard

http://www.w3.org/2001/XMLSchema#string

P2860

Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT

A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's disease

Tau interacts with src-family non-receptor tyrosine kinases

A Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers

Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein

Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice

Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path

PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A

Fyn tyrosine kinase associated with Fc epsilon RII/CD23: possible multiple roles in lymphocyte activation

P31

scholarly article

P356

10.1016/J.BIOPSYCH.2017.06.004

http://www.w3.org/2001/XMLSchema#string

P407

P577

2017-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28709498

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5729051

http://www.w3.org/2001/XMLSchema#string